Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 47 for “"Dimethyl fumarate"”.
-
The Nrf2 transcriptional target, OSGIN1, contributes to the cytoprotective properties of dimethyl fumarate
… prime target for drug discovery. Delayed-release dimethyl fumarate (DMF), currently approved for the treatment of relapsing-remitting forms of multiple sclerosis (MS), is believed to mediate its effect via the Nrf2 pathway; however, the exact mechanisms of action are unknown. The primary aim of …
-
Protective properties of dimethyl fumarate and Nrf2 signalling in response to drug toxicity
… effect promoting tissue regeneration. Dimethyl fumarate (DMF) is a drug approved for some forms of multiple sclerosis. DMF’s protection is due in part by activation of the Nrf2 pathway. We hypothesize that DMF could be used to reduce the severity of DILI via Nrf2 activation. This thesis …
-
Development of a novel combination radio- chemotherapy for glioblastoma multiforme
… more efficacious treatment options are needed. Dimethyl fumarate is a clinically available immunomodulatory drug, currently used to treat multiple sclerosis.;One of the targets of dimethyl fumarate is glutathione, a potent chemo- and radio-resistance factor. We hypothesised that the use of …
-
Selective ammonolysis of carboxylic acid derivatives
… demonstrate the ammonolysis reaction pathways. Dimethyl fumarate ammonolysis was conducted in both an ammonium hydroxide solution and an ammonia/methanol solution, the side reactions—hydrolysis and conjugate addition—were discussed respectively. We concluded that the conjugate addition …
-
The development of novel combinations therapies for the treatment of triple negative breast cancer
… or irradiation and a pre-approved fumaric acids dimethyl fumarate and monomethyl fumarate. Dimethyl fumarate and monomethyl fumarate have been shown to inhibit the NRF2 activation via the DJ-1 stabiliser which induces oxidative stress and promoted cancer cell death, dimethyl fumarate is currently …
-
Sex-Specific Cellular and Brain Systems Alterations in a Model of Autism Spectrum Disorders
… in females, led us to assess the effects of dimethyl fumarate, an activator of the anti-inflammatory nuclear factor erythroid 2-related factor 2. Therapeutic responses to dimethyl fumarate were predominantly observed in the female VPA animals, with improvements in behaviour, neuronal …
-
Σύνθεση αλκαλοειδών ως πιθανών αναστολέων γλυκοζιτασών από φυσικά χειρόμορφα υποστρώματα
… tartrate. In the cycloaddition reaction dimethyl fumarate, dimethyl maleate and N-phenyl maleimide were used as dipolarophiles. Interestingly the cycloadditions with dimethyl fumarate and dimethyl maleate gave the same cycloadduct. This result could be explained by the observed …
-
Some studies in organic photochemistry
… concerned with the photochemistry of the system dimethyl maleate/dimethyl fumarate/acetone. Irradiation of this system produced the <em>cis</em>- and <em>trans</em>-2,2-dimethyl-3,4-dimethoxycarbonyloxetanes (I and II), as well as causing <em>cis</em>↔<em>trans</em> isomerisation …
-
Cost-Utility Analysis of Medications for Relapsing-Remitting Multiple Sclerosis: A United States Third-Party Payer Perspective
… horizon versus the natural history of disease. Dimethyl fumarate demonstrates the lowest ICER at $895,073/QALY. Conclusions: DMTs for RRMS have low value versus the natural history of disease, and would not be considered cost-effective by conventional standards.
-
Therapeutic Role for Nrf2 in a Stress-Induced Rat Model System of Depression
… ability, and suicidal ideation. In recent years, dimethyl fumarate (DMF), an activator of the Nrf2 antioxidant pathway, has presented potent ameliorative capabilities to reduce inflammation, improve learning and memory, and reduce depressive-like behaviour in male rodent models of depression and …
-
Comparison of first-line therapies for relapsing-remitting multiple sclerosis
… glatiramer acetate, teriflunomide, or dimethyl fumarate). Though there are distinct differences between these treatments in regard to efficacy and safety, there is no uniform standard for making decisions about which to initiate treatment with. This review gives an overview of current …
-
Fumarate Inhibits TNF-α Release
… derivatives of a citric acid cycle intermediate, fumarate, as potential mediators of endotoxin-induced TNF-α release. We determined that 10µM dimethyl fumarate (DMF) significantly inhibited LPS-mediated soluble TNF-α released from the mouse monocyte cell line RAW 264.7, with no effect on cell …
-
Nonlinear Dynamical Characteristics of Electroencephalogram Signatures in Patients with Multiple Sclerosis
… explore the effects of Interferon-β (IFN-β) and dimethyl fumarate (DMF) on patients with MS. Data were collected from 175 participants at Jagiellonian University in Krakow, Poland, across three groups: IFN-β (n = 39), DMF (n = 53), and healthy controls (n = 83) during a resting state for six …
-
An Edge-Centric Network Modeling Approach for Assessing the Effect of Multiple Sclerosis (MS) on Brain Functional Connectivity
… prescribed for MS-Interferon Beta and Dimethyl Fumarate-on functional brain connectivity. Employing both edge-centric and traditional node-based analyses, we aimed to provide a comprehensive evaluation of brain connectivity in patients with MS. This study utilized data from 107 …
-
Development of novel combination therapies for the treatment of pancreatic cancer
… to this end we propose the use of the repurposed fumarate drugs dimethyl fumarate (DMF) and monomethyl fumarate (MMF). Both DMF and MMF were previously used for the treatment of multiple sclerosis but have since shown promise as anticancer agents, as DMF and MMF downregulate NRF2 activity, the …
-
Treatment strategies in multiple sclerosis: Current and future practice considerations
… studied the safety and efficacy of the oral DMTs dimethyl fumarate and fingolimod in our own centre, and describe their safety and efficacy in real clinical practice. The availability of oral DMTs in MS therapeutics was a watershed event and our cohorts exemplify the desire of patients to switch …
-
Diels-Alder reactions and synthetic methodologies on alumina and study of LiClO4/ether system
<p>The Diels-AIder reactions of dimethyl maleate, dimethyl fumarate, (-)-dimenthyl fumarate and (-)-menthyl methyl fumarate with cyclopentadiene on σ-Aumina and the Diels-Alder reactions of dimethyl maleate, (-)-dimenthyl fumarate and (-)-menthyl methyl fumarate with cyclopentadiene in …
-
Išsėtinė sklerozė ir kitos autoimuninės nervų sistemos ligos: klinikinis atvejis /
… immunomodulating drugs interferon beta – 1a, dimethyl fumarate was not effective, and a second line treatment with monoclonal antibody medications rituximab and ocrelizumab showed efficacy on both diseases, myasthenia gravis and multiple sclerosis. The presented case highlights the importance …
-
The use of B-haloboranes in solution and on alumina in organic chemistry
… Isomerizations of several dienes, including dimethyl maleate to dimethyl fumarate, were completed within minutes with the iodo- and bromoboronated aluminas. The solids catalyzed the Diels-Alder reactions of methyl acrylate with cyclopentadiene, isoprene with methyl acrylate, and dimethyl …
-
DETECTING, CHARACTERIZING, AND TARGETING IMMUNE OLIGODENDROGLIA USING NOVEL MAJOR HISTOCOMPATIBILITY COMPLEX REPORTER MICE
… tested three existing MS therapies and show both dimethyl fumarate and interferon modulate MHC induction in the presence of IFN, highlighting the importance of testing drugs directly on oligodendroglia under disease-relevant conditions. We conclude that understanding the role of iOLs using the …
Page 1 of 3